InVivo Therapeutics Competitors and Similar CompaniesClear all
InVivo Therapeutics's competitors and similar companies include Diasome, Semma Therapeutics, Brainstorm Cell Therapeutics and Sebacia.
 InVivo Therapeutics InVivo Therapeutics is a research and clinical-stage biomaterials and biotechnology company focused on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. |  Diasome Diasome Pharmaceuticals, Inc. is focused on the clinical and commercial development of breakthrough therapies for diabetes and obesity. |  Semma Therapeutics Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients. |  Brainstorm Cell Therapeutics BrainStorm Cell Therapeutics is a biotechnology company developing first-of-its-kind, autologous stem cell therapies for the treatment of neurodegenerative diseases. |  Sebacia Sebacia Inc. is a clinical-stage company dedicated to creating breakthrough therapies to advance dermatology. | |
Founding Date | Founding Date 2005 | Founding Date 2004 | Founding Date 2015 | Founding Date 2004 | Founding Date 2010 |
Type | Type Public | Type Private | Type Subsidiary | Type Public | Type Private |
Tags | |||||
Locations | Locations Cambridge, US HQ | Locations Cleveland, US HQ | Locations Cambridge, US HQ Cambridge, US | Locations New York, US HQ Petah Tikva, IL | Locations Duluth, US HQ |
Employees | Employees 6 | Employees 1515% increase | Employees 88 | Employees 323% increase | Employees 1 |
Valuation ($) | Valuation ($) 995.9 k | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 10.8 m | Valuation ($) N/A |
Financial | |||||
Net income | Net income ($10.5m) (FY, 2022) | Net income N/A | Net income N/A | Net income ($10.3m) (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 30m (almost 9 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 20m (almost 9 years ago) |
Total funding raised | Total funding raised $ 75.2m | Total funding raised $ 42.9m | Total funding raised $ 163m | Total funding raised N/A | Total funding raised $ 63.1m |
For sources of this data, please see the company profile
View Company Profiles
Diasome
HQ
Cleveland, US
Employees
15↑ 15% increase
Diasome Pharmaceuticals, Inc. is focused on the clinical and commercial development of breakthrough therapies for diabetes and obesity.
View companySemma Therapeutics
HQ
Cambridge, US
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
View companyBrainstorm Cell Therapeutics
HQ
New York, US
Employees
32↑ 3% increase
BrainStorm Cell Therapeutics is a biotechnology company developing first-of-its-kind, autologous stem cell therapies for the treatment of neurodegenerative diseases.
View companySebacia
HQ
Duluth, US
Employees
1
Sebacia Inc. is a clinical-stage company dedicated to creating breakthrough therapies to advance dermatology.
View company